Abstract:The serine/threonine kinase, Akt (protein kinase B) plays a central role in the regulation of intracellular cell survival. Recently, we demonstrated that the proto-oncogene TCL1, overexpressed in human T-cell prolymphocytic leukemia, is an Akt kinase co-activator. Tightly restricted TCL1 gene expression in early developmental cells suggested that the TCL1 gene is regulated at a transcriptional level. To characterize how TCL1 gene expression is regulated, we cloned the 5'-promoter of the TCL1 gene located at human chromosome 14q32. The 5'-TCL1 promoter region contains a TATA box with cis-regulatory elements for Nur77/NGFI-B (nerve growth factor-responsive element (NBRE), CCAAGGTCA), NFkappaB, and fork head transcription factor. Nur77/NGFI-B, an orphan receptor superfamily transcription factor implicated in T-cell apoptosis, is a substrate for Akt. We hypothesized that TCL1 transactivity is regulated through Akt-induced phosphorylation of Nur77/NGFI-B in vivo. In an electrophoretic mobility shift assay with chromosomal immunoprecipitation assays, wild-type Nur77, but not S350A mutant Nur77, could specifically bind to TCL1-NBRE. A luciferase assay demonstrated that TCL1-NBRE is required for inhibition of TCL1 transactivity upon nerve growth factor/platelet-derived growth factor stimulation, which activates Akt and phosphorylates Nur77. Using a chromosomal immunoprecipitation assay with reverse transcription-PCR, nerve growth factor stimulation inhibited binding of endogenous Nur77 to TCL1-NBRE, in turn, suppressing TCL1 gene expression. The results together establish that TCL1-NBRE is a novel negative regulatory element of Nur77 (NGFI-B). To the best of our knowledge, TCL1-NBRE is the first direct target of Nur77 involving the regulation of intracellular cell death survival. This Akt-induced inhibitory mechanism of TCL1 should play an important role in immunological and/or neuronal development in vivo.

Identification of nerve growth factor-responsive element of the TCL1 promoter as a novel negative regulatory element

Proto-oncogene TCL1: more than just a coactivator for Akt

The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways

The protooncogene TCL1 is an Akt kinase coactivator

Low Affinity Neurotrophin Receptor (p75ntr) Expression is Regulated by Early Growth Response (egr) Transcriptional Regulators

The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity

The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways

TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

NLRR1 is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers

Nuclear Factor Of Activated T3 Is A Negative Regulator Of Ras-Jnk1/2-Ap-1 - Induced Cell Transformation

Identification of a Human NF-κB-activating Protein, TAB3

Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins

T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation

TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia

TCL1: a new drug target in lymphoid and germ-cell malignancies?

Tbl1 and Tblr1 Phosphorylation on Regulated Gene Promoters Overcomes Dual Ctbp and Ncor/Smrt Transcriptional Repression Checkpoints

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia

Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1

A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes